Ligand Pharmaceuticals Incorporated (LGND) delivered a return of 81.05% over the past year. Since LGND does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Ligand Pharmaceuticals Incorporated one year ago would be worth $18,105 today, representing a gain of $8,105.

Ligand Pharmaceuticals Incorporated (LGND) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LGND, the total return equals the price-only return.

Yes, Ligand Pharmaceuticals Incorporated (LGND) outperformed the S&P 500 by 64.37 percentage points over the past year. LGND delivered a total return of 81.05%, compared to the S&P 500's 16.68%. This 64.37pp alpha means investors in LGND earned more than a passive S&P 500 index fund.

Ligand Pharmaceuticals Incorporated (LGND) experienced a maximum drawdown of -20.91% over the past year, declining from its peak on 2025-03-06 to its trough on 2025-04-08. The stock recovered to its prior peak by 2025-06-24. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Ligand Pharmaceuticals Incorporated (LGND) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 104.3% (7.4% CAGR) — $10,000 would have grown to $20,427. Over 20 years: 362.0% total return (8.0% CAGR) — $10,000 → $46,203. Over 30 years: 397.1% total return (5.5% CAGR) — $10,000 → $49,706. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Ligand Pharmaceuticals Incorporated's best calendar year was 2003 with a total return of 330.5%. Its worst year was 2002 with a total return of -68.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 399.0 percentage points.